Literature DB >> 8691132

T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptides.

S L Larsen1, L O Pedersen, S Buus, A Stryhn.   

Abstract

Endocytosed protein antigens are believed to be fragmented in what appears to be a balance between proteolysis and MHC-mediated epitope protection, and the resulting peptide-MHC complexes are transported to the surface of the antigen-presenting cells (APC) and presented to T cells. The events that lead to antigenic peptide generation and the compartments where antigen processing takes place remains somewhat enigmatic. The importance of intracellular antigen processing has been well established; however, it is unclear whether additional processing occurs at the APC surface. To follow antigen processing, we have identified a pair of T cell hybridomas that recognize a long vs. a short version of the same epitope. We have used prefixed APC and various protease inhibitors to demonstrate that the APC surface has a considerable potential for antigen processing. Specific antibodies further identified the exopeptidase Aminopeptidase N (APN, CD13) as one of the enzymes involved in the observed cell-surface antigen processing. The NH2-terminal end of the longer peptide could, even while bound to major histocompatibility complex (MHC) class II molecules, be digested by APN with dramatic consequences for T cell antigen recognition. This could be demonstrated both in cell-free systems using purified reagents and in cellular systems. Thus, MHC class II and APN may act in concert to generate the final T cell epitopes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691132      PMCID: PMC2192675          DOI: 10.1084/jem.184.1.183

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

1.  Oligopeptide antigens of the angiotensin lineage compete for presentation by paraformaldehyde-treated accessory cells to T cells.

Authors:  S Buus; O Werdelin
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

2.  Isolation and characterization of antigen-Ia complexes involved in T cell recognition.

Authors:  S Buus; A Sette; S M Colon; D M Jenis; H M Grey
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

3.  Binding of immunogenic peptides to Ia histocompatibility molecules.

Authors:  B P Babbitt; P M Allen; G Matsueda; E Haber; E R Unanue
Journal:  Nature       Date:  1985 Sep 26-Oct 2       Impact factor: 49.962

4.  Separation and characterization of two component tumor lines within the AKR lymphoma, AKTB-1, by fluorescence-activated cell sorting and flow microfluorometry analysis. II. Differential histopathology of sIg+ and sIg- sublines.

Authors:  B J Mathieson; M M Zatz; S O Sharrow; R Asofsky; W Logan; C Kanellopoulos-Langevin
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

5.  Transplantable B-cell lymphomas in B10. H-2aH-4bp/Wts mice.

Authors:  L L Lanier; L W Arnold; R B Raybourne; S Russell; M A Lynes; N L Warner; G Haughton
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

6.  Specificity of the T cell receptor: two different determinants are generated by the same peptide and the I-Ak molecule.

Authors:  P M Allen; G R Matsueda; E Haber; E R Unanue
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

7.  Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes.

Authors:  K Ziegler; E R Unanue
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

8.  Antigen presentation by human monocytes: evidence for stimulant processing and requirement for interleukin 1.

Authors:  G Scala; J J Oppenheim
Journal:  J Immunol       Date:  1983-09       Impact factor: 5.422

9.  Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas.

Authors:  P M Allen; D J Strydom; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

10.  Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.

Authors:  R Shimonkevitz; J Kappler; P Marrack; H Grey
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more
  37 in total

1.  Getting peptide vaccines to work: just a matter of quality control?

Authors:  Esteban Celis
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  MHC class II epitope predictive algorithms.

Authors:  Morten Nielsen; Ole Lund; Søren Buus; Claus Lundegaard
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

Review 3.  Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis.

Authors:  Linda Yip; C Garrison Fathman
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

4.  Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.

Authors:  Alexei von Delwig; Julie A Musson; Joe Gray; Norman McKie; John H Robinson
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

5.  Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules.

Authors:  C A Nelson; I Vidavsky; N J Viner; M L Gross; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 6.  CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders.

Authors:  Chenyang Lu; Mohammad A Amin; David A Fox
Journal:  J Immunol       Date:  2020-01-01       Impact factor: 5.422

7.  Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation.

Authors:  D E Wentworth; K V Holmes
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

Review 8.  Biomarkers in chronic graft-versus-host disease.

Authors:  Jacob Rozmus; Kirk R Schultz
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

9.  Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.

Authors:  Hisaki Fujii; Geoff Cuvelier; Kevin She; Soudabeh Aslanian; Hiromi Shimizu; Amina Kariminia; Mark Krailo; Zhengjia Chen; Rob McMaster; Axel Bergman; Frederick Goldman; Stephen A Grupp; Donna A Wall; Andrew L Gilman; Kirk R Schultz
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

10.  Peptide length significantly influences in vitro affinity for MHC class II molecules.

Authors:  Cathal O'Brien; Darren R Flower; Conleth Feighery
Journal:  Immunome Res       Date:  2008-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.